Subarachnoid hemorrhage: Difference between revisions

(Major update: Ottawa SAH Rule, CT sensitivity by time, Hunt-Hess grade, LP xanthochromia timing, nimodipine for vasospasm, nicardipine for BP, aminocaproic acid, references with PMIDs)
(Embed Ottawa SAH Calculator on clinical page)
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Background==
==Background==
*Bleeding into the subarachnoid space (between arachnoid and pia mater)
*Bleeding into the subarachnoid space (between arachnoid and pia mater)
*'''Ruptured cerebral aneurysm''' accounts for '''~85%''' of nontraumatic SAH
*Ruptured cerebral aneurysm accounts for ~85% of nontraumatic SAH
**Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%)
**Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%)
*Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use
*Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use
*'''Mortality: ~50% overall''' (25% die before reaching hospital, 25% die within 30 days)
*Mortality: ~50% overall (25% die before reaching hospital, 25% die within 30 days)
*Risk factors:
*Risk factors:
**[[Hypertension]] (most important modifiable risk factor)
**[[Hypertension]] (most important modifiable risk factor)
**Smoking, heavy alcohol use
**Smoking, heavy alcohol use
**'''Family history''' of SAH or aneurysm (first-degree relative)
**Family history of SAH or aneurysm (first-degree relative)
**'''Polycystic kidney disease''', Ehlers-Danlos, connective tissue disorders
**Polycystic kidney disease, Ehlers-Danlos, connective tissue disorders
**Prior SAH (risk of rebleeding)
**Prior SAH (risk of rebleeding)
**Sympathomimetic drug use ([[cocaine]], [[amphetamines]])
**Sympathomimetic drug use ([[cocaine]], [[amphetamines]])
Line 15: Line 15:


==Clinical Features==
==Clinical Features==
*'''"Worst headache of my life"''' — sudden onset, maximal at onset ('''thunderclap headache''')
*"Worst headache of my life" — sudden onset, maximal at onset (thunderclap headache)
*'''Sentinel headache''': warning leak days-weeks before major rupture (present in ~30-50%)
*'''Sentinel headache''': warning leak days-weeks before major rupture (present in ~30-50%)
*'''Meningismus''' (neck stiffness, photophobia) — may take 6-12 hours to develop
*Meningismus (neck stiffness, photophobia) — may take 6-12 hours to develop
*'''Loss of consciousness''' at onset (~50%)
*Loss of consciousness at onset (~50%)
*Nausea, vomiting (common)
*Nausea, vomiting (common)
*'''Focal neurologic deficits''' (CN III palsy → posterior communicating artery aneurysm)
*Focal neurologic deficits (CN III palsy → posterior communicating artery aneurysm)
*'''Seizures''' (~10% at onset)
*Seizures (~10% at onset)
*'''Terson syndrome''': intraocular hemorrhage (subhyaloid/vitreous) associated with severe SAH
*Terson syndrome: intraocular hemorrhage (subhyaloid/vitreous) associated with severe SAH
*'''May present as syncope, cardiac arrest, or altered mental status without headache'''
*'''May present as syncope, cardiac arrest, or altered mental status without headache'''


Line 46: Line 46:
==Evaluation==
==Evaluation==
===Non-Contrast CT Head===
===Non-Contrast CT Head===
*'''First-line test'''
*First-line test
*'''Sensitivity ~98% within 6 hours''' of onset, ~93% at 12 hours, decreasing to ~50% by day 5-7<ref>Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. ''BMJ''. 2011;343:d4277. PMID 21768192</ref>
*Sensitivity ~98% within 6 hours of onset, ~93% at 12 hours, decreasing to ~50% by day 5-7<ref>Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. ''BMJ''. 2011;343:d4277. PMID 21768192</ref>
*Fisher grade: amount of blood predicts vasospasm risk
*Fisher grade: amount of blood predicts vasospasm risk
*'''Modern thin-cut CT with experienced radiologist within 6 hours may approach 100% sensitivity'''
*Modern thin-cut CT with experienced radiologist within 6 hours may approach 100% sensitivity


===Lumbar Puncture===
===Lumbar Puncture===
*'''Required if CT negative and clinical suspicion remains'''
*Required if CT negative and clinical suspicion remains
*'''Classic finding: xanthochromia''' (yellow discoloration from bilirubin in CSF)
*Classic finding: xanthochromia (yellow discoloration from bilirubin in CSF)
**Takes '''6-12 hours''' to develop — '''LP performed <6 hours after onset may miss xanthochromia'''
**Takes 6-12 hours to develop — LP performed <6 hours after onset may miss xanthochromia
*'''Elevated RBCs that do NOT clear''' across sequential tubes (vs traumatic tap which clears)
*'''Elevated RBCs that do NOT clear''' across sequential tubes (vs traumatic tap which clears)
*'''Elevated opening pressure'''
*Elevated opening pressure
*Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important
*Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important


===Ottawa SAH Rule===
===Ottawa SAH Rule===
*For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour
*For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour
*'''100% sensitivity''' (validation study) — if '''none present, SAH effectively ruled out'''<ref>Perry JJ, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. ''JAMA''. 2013;310(12):1248-1255. PMID 24065011</ref>:
*100% sensitivity (validation study) — if none present, SAH effectively ruled out<ref>Perry JJ, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. ''JAMA''. 2013;310(12):1248-1255. PMID 24065011</ref>:
**Age ≥40
**Age ≥40
**Neck pain or stiffness
**Neck pain or stiffness
Line 70: Line 70:


===CT Angiography (CTA)===
===CT Angiography (CTA)===
*'''Obtain with initial CT''' if SAH confirmed or high suspicion
*Obtain with initial CT if SAH confirmed or high suspicion
*Identifies aneurysm location and morphology for surgical/endovascular planning
*Identifies aneurysm location and morphology for surgical/endovascular planning
*Sensitivity >95% for aneurysms >3 mm
*Sensitivity >95% for aneurysms >3 mm
Line 82: Line 82:
==Management==
==Management==
===ED Management===
===ED Management===
*'''ABCs, IV access, continuous monitoring'''
*ABCs, IV access, continuous monitoring
*'''Blood pressure control''':
*Blood pressure control:
**'''Target SBP <160 mmHg''' until aneurysm secured (reduce rebleeding risk)
**Target SBP <160 mmHg until aneurysm secured (reduce rebleeding risk)
**'''Nicardipine infusion''' (5-15 mg/hr, titrate q5min) — preferred
**Nicardipine infusion (5-15 mg/hr, titrate q5min) — preferred
**Labetalol 10-20 mg IV q10-20min
**Labetalol 10-20 mg IV q10-20min
**'''Avoid nitroprusside''' (increases ICP)
**Avoid nitroprusside (increases ICP)
*'''Seizure management''': benzodiazepines acutely; prophylactic AEDs controversial
*Seizure management: benzodiazepines acutely; prophylactic AEDs controversial
*'''Treat headache''': acetaminophen; short-acting opioids cautiously
*Treat headache: acetaminophen; short-acting opioids cautiously
**'''Avoid ketorolac''' (platelet inhibition)
**Avoid ketorolac (platelet inhibition)
*'''Aminocaproic acid''' (tranexamic acid): may reduce rebleeding risk before aneurysm secured — '''4g IV loading dose''' (discuss with neurosurgery)
*Aminocaproic acid (tranexamic acid): may reduce rebleeding risk before aneurysm secured — 4g IV loading dose (discuss with neurosurgery)
*'''Reverse anticoagulation''' if applicable
*Reverse anticoagulation if applicable


===Definitive Treatment===
===Definitive Treatment===
*'''Neurosurgery/neurointerventional consultation emergently'''
*Neurosurgery/neurointerventional consultation emergently
*'''Aneurysm securing''' (within 24 hours ideally):
*Aneurysm securing (within 24 hours ideally):
**'''Endovascular coiling''' (preferred for most aneurysms) OR
**Endovascular coiling (preferred for most aneurysms) OR
**'''Surgical clipping'''
**Surgical clipping
*'''ICU admission'''
*ICU admission


===Complications (Post-Hemorrhage)===
===Complications (Post-Hemorrhage)===
*'''Rebleeding''': highest risk in first 24 hours (~4%); '''most devastating complication'''
*'''Rebleeding''': highest risk in first 24 hours (~4%); '''most devastating complication'''
*'''Vasospasm''': occurs '''days 3-14''' (peak day 7); monitor with daily TCDs
*Vasospasm: occurs days 3-14 (peak day 7); monitor with daily TCDs
**Treat with '''nimodipine 60 mg PO/NG q4h x 21 days''' (improves outcomes; does not prevent vasospasm)
**Treat with nimodipine 60 mg PO/NG q4h x 21 days (improves outcomes; does not prevent vasospasm)
**Triple-H therapy (hypertension, hypervolemia, hemodilution) — '''only after aneurysm secured'''
**Triple-H therapy (hypertension, hypervolemia, hemodilution) — only after aneurysm secured
*'''Hydrocephalus''': acute (requires EVD) or chronic (VP shunt)
*Hydrocephalus: acute (requires EVD) or chronic (VP shunt)
*'''Hyponatremia''': cerebral salt wasting vs SIADH
*Hyponatremia: cerebral salt wasting vs SIADH
*'''Neurogenic cardiac dysfunction''': Takotsubo-like, neurogenic pulmonary edema
*Neurogenic cardiac dysfunction: Takotsubo-like, neurogenic pulmonary edema


==Disposition==
==Disposition==
*'''All confirmed SAH: emergent neurosurgical consultation and ICU admission'''
*All confirmed SAH: emergent neurosurgical consultation and ICU admission
*'''Transfer to neurosurgical center''' if local capabilities unavailable
*Transfer to neurosurgical center if local capabilities unavailable
*'''SAH ruled out''' (negative CT + negative LP): may discharge with headache precautions and PCP follow-up
*SAH ruled out (negative CT + negative LP): may discharge with headache precautions and PCP follow-up
 
== Calculators ==
{{Ottawa SAH Calculator}}
{{Fisher Scale Calculator}}


==See Also==
==See Also==

Latest revision as of 09:56, 22 March 2026

Background

  • Bleeding into the subarachnoid space (between arachnoid and pia mater)
  • Ruptured cerebral aneurysm accounts for ~85% of nontraumatic SAH
    • Most common locations: anterior communicating artery (30%), posterior communicating artery (25%), MCA bifurcation (20%)
  • Other causes: arteriovenous malformation, perimesencephalic (benign, ~10%), vasculitis, coagulopathy, drug use
  • Mortality: ~50% overall (25% die before reaching hospital, 25% die within 30 days)
  • Risk factors:
    • Hypertension (most important modifiable risk factor)
    • Smoking, heavy alcohol use
    • Family history of SAH or aneurysm (first-degree relative)
    • Polycystic kidney disease, Ehlers-Danlos, connective tissue disorders
    • Prior SAH (risk of rebleeding)
    • Sympathomimetic drug use (cocaine, amphetamines)
  • Peak incidence: age 40-60; female predominance (1.6:1)

Clinical Features

  • "Worst headache of my life" — sudden onset, maximal at onset (thunderclap headache)
  • Sentinel headache: warning leak days-weeks before major rupture (present in ~30-50%)
  • Meningismus (neck stiffness, photophobia) — may take 6-12 hours to develop
  • Loss of consciousness at onset (~50%)
  • Nausea, vomiting (common)
  • Focal neurologic deficits (CN III palsy → posterior communicating artery aneurysm)
  • Seizures (~10% at onset)
  • Terson syndrome: intraocular hemorrhage (subhyaloid/vitreous) associated with severe SAH
  • May present as syncope, cardiac arrest, or altered mental status without headache

Hunt-Hess Grading

  • Grade I: asymptomatic or mild headache
  • Grade II: moderate-severe headache, nuchal rigidity, CN palsy
  • Grade III: drowsiness, confusion, mild focal deficit
  • Grade IV: stupor, moderate-severe hemiparesis
  • Grade V: coma, decerebrate posturing

Differential Diagnosis

Headache

Common

Killers

Maimers

Others

Aseptic Meningitis

Evaluation

Non-Contrast CT Head

  • First-line test
  • Sensitivity ~98% within 6 hours of onset, ~93% at 12 hours, decreasing to ~50% by day 5-7[1]
  • Fisher grade: amount of blood predicts vasospasm risk
  • Modern thin-cut CT with experienced radiologist within 6 hours may approach 100% sensitivity

Lumbar Puncture

  • Required if CT negative and clinical suspicion remains
  • Classic finding: xanthochromia (yellow discoloration from bilirubin in CSF)
    • Takes 6-12 hours to develop — LP performed <6 hours after onset may miss xanthochromia
  • Elevated RBCs that do NOT clear across sequential tubes (vs traumatic tap which clears)
  • Elevated opening pressure
  • Traumatic tap vs SAH: controversial; visual xanthochromia and clinical context are most important

Ottawa SAH Rule

  • For alert patients >15 years with new severe nontraumatic headache reaching maximum intensity within 1 hour
  • 100% sensitivity (validation study) — if none present, SAH effectively ruled out[2]:
    • Age ≥40
    • Neck pain or stiffness
    • Witnessed loss of consciousness
    • Onset during exertion
    • Thunderclap headache (instant peak)
    • Limited neck flexion on exam

CT Angiography (CTA)

  • Obtain with initial CT if SAH confirmed or high suspicion
  • Identifies aneurysm location and morphology for surgical/endovascular planning
  • Sensitivity >95% for aneurysms >3 mm

Labs

  • CBC, BMP, coagulation studies (PT/INR, PTT)
  • Type and screen
  • Troponin (neurogenic myocardial stunning)
  • Finger stick glucose

Management

ED Management

  • ABCs, IV access, continuous monitoring
  • Blood pressure control:
    • Target SBP <160 mmHg until aneurysm secured (reduce rebleeding risk)
    • Nicardipine infusion (5-15 mg/hr, titrate q5min) — preferred
    • Labetalol 10-20 mg IV q10-20min
    • Avoid nitroprusside (increases ICP)
  • Seizure management: benzodiazepines acutely; prophylactic AEDs controversial
  • Treat headache: acetaminophen; short-acting opioids cautiously
    • Avoid ketorolac (platelet inhibition)
  • Aminocaproic acid (tranexamic acid): may reduce rebleeding risk before aneurysm secured — 4g IV loading dose (discuss with neurosurgery)
  • Reverse anticoagulation if applicable

Definitive Treatment

  • Neurosurgery/neurointerventional consultation emergently
  • Aneurysm securing (within 24 hours ideally):
    • Endovascular coiling (preferred for most aneurysms) OR
    • Surgical clipping
  • ICU admission

Complications (Post-Hemorrhage)

  • Rebleeding: highest risk in first 24 hours (~4%); most devastating complication
  • Vasospasm: occurs days 3-14 (peak day 7); monitor with daily TCDs
    • Treat with nimodipine 60 mg PO/NG q4h x 21 days (improves outcomes; does not prevent vasospasm)
    • Triple-H therapy (hypertension, hypervolemia, hemodilution) — only after aneurysm secured
  • Hydrocephalus: acute (requires EVD) or chronic (VP shunt)
  • Hyponatremia: cerebral salt wasting vs SIADH
  • Neurogenic cardiac dysfunction: Takotsubo-like, neurogenic pulmonary edema

Disposition

  • All confirmed SAH: emergent neurosurgical consultation and ICU admission
  • Transfer to neurosurgical center if local capabilities unavailable
  • SAH ruled out (negative CT + negative LP): may discharge with headache precautions and PCP follow-up

Calculators

Template:Ottawa SAH Calculator

Modified Fisher Scale

Modified Fisher Scale — SAH Vasospasm Risk
CT Findings Select Grade
Grade

1 Grade 0 — No SAH or IVH (0)

Grade 1 — Thin SAH, no IVH (1)

Grade 2 — Thin SAH with IVH (2)

Grade 3 — Thick SAH, no IVH (3)

Grade 4 — Thick SAH with IVH (4)

Modified Fisher Grade
Interpretation — Risk of Symptomatic Vasospasm
Grade Vasospasm Risk Description
0 | ~0% | No subarachnoid blood detected.
1 | ~24% | Focal or diffuse thin SAH, no intraventricular hemorrhage (IVH).
2 | ~33% | Focal or diffuse thin SAH with IVH.
3 | ~33% | Focal or diffuse thick SAH (>1mm), no IVH.
4 | ~40% | Focal or diffuse thick SAH with IVH. Highest vasospasm risk.
References
  • Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6(1):1-9. PMID 7354892.
  • Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery. 2006;59(1):21-27. PMID 16823296.

See Also

References

  1. ↑ Perry JJ, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage. BMJ. 2011;343:d4277. PMID 21768192
  2. ↑ Perry JJ, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 2013;310(12):1248-1255. PMID 24065011
  • Connolly ES Jr, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline from the AHA/ASA. Stroke. 2012;43(6):1711-1737. PMID 22556195
  • Edlow JA, et al. Diagnosis of subarachnoid hemorrhage. Stroke. 2023;54(4):1058-1072. PMID 36848423
  • van Gijn J, et al. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306-318. PMID 17258671
Retrieved from "https://www.wikem.org/w/index.php?title=Subarachnoid_hemorrhage&oldid=389553"